Friday, September 11, 2015

What's Next in the Hepatitis C Drug Pipeline: Latest developments in hepatitis C treatment at Merck

What's Next in the Hepatitis C Drug Pipeline
Published on Sep 11, 2015
Specialty Pharmacy Times

Janice Wahl, MD, Executive Director of Infections Diseases at Merck Research Laboratories, discusses the latest developments in hepatitis C treatment at Merck.

No comments:

Post a Comment